Uterine Artery Doppler Indices and Uterocervical Angle Measurment in Prediction of Preterm Labor

NCT ID: NCT07336173

Last Updated: 2026-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

47 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-01-15

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to evaluate the role of uterine artery doppler indices and uterocervical angle measurement in prediction of preterm labor .The main question it aims to answer is:

Does combination of both uterine artery doppler indices and uterocervical angle measurement increase sensitivity and specificity for prediction of established preterm labor ? Participants already performing uterine artery doppler as part of their regular antenatal care .measurement of anterior uterocervical angle will be added between 24 to 34 weeks gestation to predict preterm labor in candidates .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study the aim is to evaluate the combined predictive value of both uterine artery doppler and uterocervical angle measurement in a prospective cohort study design to predict preterm labor . The abnormal mid-trimester uterine artery resistance, pulsatility index and diastolic notching measured with Doppler sonography is known to be predictive for preeclampsia and, hence, for iatrogenic Preterm labor. It will be measured via trans abdominal approach.

The measurement of UCA in the second trimester of pregnancy is strongly associated with the occurrence of spontaneous Preterm labor and will be measured via transvaginal approach .

Both measurement will be conducted between 24 to 34 weeks gestational .

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preterm Labor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound

Trans abdominal ultrasound will be used to measure uterine artery doppler indices Trans vaginal ultrasound will be used to measure anterior uterocervical angle

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patient who will give verbal \& written will informed consent.
2. Pregnant women between 18 and 40 years old of age
3. Singleton pregnancy
4. Gestational age will be confirmed by first trimester ultrasound scan (\<14 weeks).
5. Gestational age between 24 and 34 weeks .
6. Threatened preterm labor which is defined as:

Presence of at least one uterine contraction every 10 minutes lasting ≥30 seconds . Cervical dilatation ≤3 cm . Cervical effacement \<80%.

Exclusion Criteria

Obstetric:

1. Ruptured membranes
2. Clinical evidence of Chorioamnionitis.
3. Fetal compromise on evaluation.
4. Severe obstetric complications (e.g., severe Preeclampsia, Eclampsia).
5. Diagnosed intrauterine growth restriction (IUGR).
6. Congenital fetal anomalies.
7. Multiple pregnancies.
8. Prior cervical surgery (e.g., cone biopsy, cerclage).

Non-Obstetric:

1. Significant maternal medical disorders (e.g., chronic hypertension, diabetes mellitus, liver dysfunction).
2. Severe non-obstetric complications (e.g., acute abdomen).
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kafrelsheikh University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nourhan Moustafa Elsayed Shalaby

Resident physician doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kafr elsheikh university hospital

Kafr ash Shaykh, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nourhan M Shalaby, Master

Role: CONTACT

+201060674910

Ahmed M Fathy, MD

Role: CONTACT

+2 0122 1485021

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kafrelshiekh university

Role: primary

+20 47 310 9590

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KFSIRB200-597

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.